Chitin synthase inhibitor 4 (50 μg/mL) has considerable curative and protective effects against S. sclerotiorum vivo, and no obvious phytotoxicity . Chitin synthase inhibitor 4 has low acute toxicity, with no carcinogenic and mutagenic toxicity risk.